JACOBS LEVY EQUITY MANAGEMENT, INC
Position in TVTX — Travere Therapeutics, Inc.
CIK 884414
FLORHAM PARK, NJ
Position in TVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,676,500
+$707,776 QoQ
Shares Held
205,536
-44.3% QoQ
Ownership
0.218%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#71
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. TVTX ranks #14 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,503 | $159,939,880 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
2,939,719 | $98,157,217 | |
| 3 | INCY |
Incyte Corp
|
731,774 | $82,953,900 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
695,532 | $60,476,507 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
322,377 | $25,232,447 | |
| 6 | EXEL |
Exelixis, Inc.
|
415,650 | $22,615,516 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,231,516 | $20,898,826 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
60,986 | $18,358,615 |
All Filings in TVTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,676,500 | 205,536 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,968,724 | 369,193 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,275,662 | 268,926 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,603,689 | 318,146 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $10,881,714 | 735,251 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,466,536 | 863,088 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $37,874,790 | 2,174,213 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $22,249,374 | 1,590,377 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $15,534,517 | 1,889,844 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,671,321 | 1,124,685 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $15,446,600 | 1,718,198 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,945,623 | 1,671,770 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $23,420,928 | 1,524,800 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $32,964,762 | 1,465,752 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $18,596,029 | 884,262 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $17,940,728 | 728,114 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $13,517,989 | 557,903 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $23,848,691 | 925,444 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $29,149,415 | 939,092 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $25,035,651 | 1,032,398 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,539,683 | 790,931 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $16,010,064 | 641,172 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $17,608,092 | 646,050 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 RTRX | — | 669,375 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 RTRX | — | 684,246 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 RTRX | — | 599,891 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||